Clinical Trial Update: Long-Term Non-Interventional Latanoprost Study

View source ↗

Summary

Long-term non-interventional trial of latanoprost completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Ocular Hypertension | Status: COMPLETED | Results posted: 2018-11-05